Lisa Pham
Reporter at Bloomberg News
Journalist and writer. Currently a Bloomberg reporter in London via Hong Kong, New York, Sydney. Previously freelanced for IHT, NYT in Paris. Opinions my own.
Articles
-
2 days ago |
news.bloombergtax.com | Lisa Pham
XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
-
2 days ago |
bloomberglinea.com | Alice French |Kanoko Matsuyama |Lisa Pham |Simon Dawson
Bloomberg — Las acciones de las empresas farmacéuticas cayeron en todo el mundo después de que el presidente de EE.UU., Donald Trump, anunciara su intención de ordenar una reducción de los costos de los medicamentos recetados en EE.UU. para equipararlos a los de otros países. Esto generó preocupación sobre el impacto en las ganancias del sector. Farmacéuticas europeas, entre ellas Novo Nordisk A/S (NVO), AstraZeneca Plc (AZN) y Roche Holding AG, se desplomaron.
-
2 days ago |
bloomberg.com | Alice French |Kanoko Matsuyama |Lisa Pham
Las acciones de las empresas farmacéuticas cayeron en todo el mundo después de que el presidente de EE.UU., Donald Trump, anunciara su intención de ordenar una reducción de los costos de los medicamentos recetados en EE.UU. para equipararlos a los de otros países. Esto generó preocupación sobre el impacto en las ganancias del sector. Farmacéuticas europeas, entre ellas Novo Nordisk A/S, AstraZeneca Plc y Roche Holding AG, se desplomaron.
-
2 days ago |
bloomberg.com | Lisa Pham
AstraZeneca branding. (Bloomberg) -- AstraZeneca Plc lost its crown as the UK’s most valuable listed company after US President Donald Trump’s plans to lower drug prices sent shares of pharmaceuticals companies lower across the world. The stock slipped as much as 5.8% on Monday, reducing AstraZeneca’s market capitalization to roughly £154 billion ($203 billion) and taking it below HSBC Holdings Plc’s £156 billion.
-
3 days ago |
bloomberg.com | Alice French |Kanoko Matsuyama |Lisa Pham
Capsules of Takeda Pharmaceutical Co.'s Prevacid heartburn drug. Photographer: JB Reed/Bloomberg(Bloomberg) -- Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries, prompting concern that profits will take a hit.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 615
- DMs Open
- No
RT @BbgGulyas: Finland's Neste has attracted more attention from short sellers than any other oil stock in Europe’s benchmark equity index,…
RT @PhilSerafino: Hearing aid makers have become one of the stock market’s less likely artificial intelligence plays https://t.co/626ZoxUdf…
RT @PhilSerafino: Novo Nordisk has fallen behind Eli Lilly this year in the race to be the big stock market winner from obesity drugs. Anal…
